Genotype-Based Molecular Mechanisms in Alport Syndrome.

Area of Science:

• Genetics
• Nephrology
• Molecular Biology

Background:

• Alport syndrome is an inherited disorder affecting kidneys, hearing, and eyes.
• It stems from pathogenic variants in COL4A3, COL4A4, or COL4A5 genes, crucial for glomerular basement membrane type 4 collagen.
• Animal models (dogs, mice, rats) replicate its genetic and mutation diversity.

Purpose of the Study:

• To review genotype-phenotype mechanisms in Alport syndrome.
• To explore how these mechanisms inform precision medicine strategies.
• To elucidate the molecular basis of different Alport syndrome inheritance patterns and mutation types.

Main Methods:

• Review of existing literature on Alport syndrome genetics and molecular pathology.
• Analysis of data from animal models reflecting autosomal and X-linked inheritance.
• In vitro and knockout model studies investigating missense and protein-truncating variants.

Main Results:

• Pathogenic variants in COL4A3, COL4A4, or COL4A5 cause Alport syndrome.
• Protein-truncating variants prevent α3α4α5(IV) collagen synthesis, unlike missense variants.
• Missense variants lead to impaired collagen trafficking and ER stress; protein-truncating variants induce biomechanical strain and receptor activation.

Conclusions:

• Genotype-phenotype correlations are critical for understanding Alport syndrome.
• Molecular mechanisms, including collagen synthesis, trafficking, and cellular stress, drive disease progression.
• This knowledge is foundational for developing precision medicine approaches to Alport syndrome treatment.